Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis.

To assess the effects and toxicity of the following agents:Prostaglandin analogues together with other agents proposed for the treatment of Raynaud's phenomenom (RP) in scleroderma.